| GTO ID | GTC2230 |
| Trial ID | NCT04153279 |
| Disease | Cytomegalovirus Infection |
| Altered gene | CMV |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | CMV TCR-T cells |
| HLA | HLA-A*11:01|HLA-A*02:01|HLA-A*24:02 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Pilot Study of CMV-TCR-T Cells in CM Virus Infection Diseases After HSCT |
| Year | 2019 |
| Country | China |
| Company sponsor | Hebei Yanda Ludaopei Hospital |
| Other ID(s) | HXYT-005 |
| Cohort 1 | |||||||||||
|
|||||||||||